PDL BioPharma, Inc. PDLI

Other  —  Other
Market cap
—
P/E
0.0×
Older periods Dec '19 Mar '20 Jun '20 Dec '20
P/E ratio

+8 more quarters

0.00 0.00 0.00 —
P/S ratio
7.04 4.93 6.02 —
P/FCF ratio
5.49 4.66 0.00 —
P/Operating CF
(20.14) (17.48) (15.43) —
P/B ratio
0.65 0.48 0.74 —
EV/Sales
4.45 2.86 4.24 —
EV/EBITDA
0.00 0.00 0.00 —
EV/FCF
3.47 2.70 (32.11) —
Current Ratio
6.87 13.21 13.68 —
Net Debt/EBITDA
1.61 3.67 7.25 —
Debt/Equity
0.05 0.02 0.03 —
Earnings Yield
(19.38%) (43.32%) (49.44%) —
Free Cash Flow Yield
18.23% 21.48% (2.20%) —
Free Cash Flow per Share
0.01 (0.12) (0.18) —
Book value per Share
5.00 4.50 3.62 —
Free Cash Flow
1.58 (15.35) (20.35) —
EV/EBIT
0.00 0.00 0.00 —
Other line items

Show all line items

Columns are period end dates